Results 91 to 100 of about 445,817 (266)

Real‐world insights on switching aflibercept dosage for enhanced outcomes in age‐related macular degeneration (RISE‐AMD): Safety data

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate real‐world safety experience with aflibercept 8 mg in a large case series of patients with neovascular age‐related macular degeneration (nAMD). Methods Due to a high proportion of patients on short treatment intervals, patients with nAMD at a Danish tertiary retina clinic were systematically switched to aflibercept 8 mg ...
Mary Graciya Karunainathan, Celine Lee, Kaweh Daniel Zohalinejad, Mads Odgaard Mæng, Nanna Würtz Fabrin, Sigurrós Jónsdóttir, Anne Kjærsgaard Hassing, Søren Kveiborg Yde, Charles C. Wykoff, Henrik Vorum, Yousif Subhi, Marie Ørskov, Lasse Jørgensen Cehofski   +12 more
wiley   +1 more source

EFFECT OF ANTI-VEGF THERAPY ON THE STRUCTURAL STATE OF THE RETINA IN DIABETIC MACULAR EDEMA

Acta Biomedica Scientifica, 2016
Objective: to analyze the structural state of the central area of the retina in diabetic macular edema in the background anti-VEGF therapy. Methods. The study included 38 patients (40 eyes) with diabetic macular edema.
M. M. Bikbov, R. R. Fayzrakhmanov, R. M. Zaynullin   +2 more
doaj   +1 more source

Real‐world incidence and clinical characteristics of intraocular inflammation following intravitreal faricimab therapy: A safety study

Acta Ophthalmologica, EarlyView.
Abstract Purpose To estimate the real‐world incidence of intraocular inflammation (IOI) following intravitreal faricimab injections at a large, highly specialized tertiary centre. Methods Single‐centre, retrospective cohort study with chart review using an electronic injection database and electronic medical records from November 2023 to August 2024 ...
Miklos Schneider, Leyla Turan, Farah Arif, Jakob Bjerager, Oliver Niels Klefter, Carsten Faber, Yousif Subhi, Javad Nouri Hajari   +7 more
wiley   +1 more source

The Difference Of Visual Acuity And Macular Thickness Post Bevacizumab Therapy In Secondary Macular Edema Retinal Vein Occlusion

Journal of Agromedicine and Medical Sciences (AMS), 2018
Retinal vein occlusion is the second most common cause of blindness in retinal vascular disease after diabetic retinopathy and may lead to complications of macular edema.
Citra Rahmadani, Nur Khoma Fatmawati, Rahmat Bakhtiar   +2 more
doaj   +1 more source

Visual function and disability are associated with microcystic macular edema, macular and peripapillary vessel density in patients with neuromyelitis optica spectrum disorder. [PDF]

Front Neurol, 2022
Li J, Chen Y, Zhang Y, He Z, Yu H, Shi C, Shen M, Lu F.   +7 more
europepmc   +1 more source

Microperimetry and OCT angiography evaluation of patients with ischemic diabetic macular edema treated with monthly intravitreal bevacizumab: a pilot study

International Journal of Retina and Vitreous, 2019
Functional and anatomical evaluation of patients with ischemic diabetic macular edema after monthly injections of Bevacizumab. Five eyes from five patients with diabetic macular edema associated with macular ischemia in fluorescein angiography (FA ...
Felipe Pereira, Bruno Rebello Godoy, M. Maia, C. Regatieri   +3 more
semanticscholar   +1 more source

Impact of delayed appointments on treatment outcomes in neovascular macular degeneration

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate the real‐world visual outcomes of anti‐vascular endothelial growth factor (anti‐VEGF) therapy, the frequency of delayed appointments and the relationship between delays and visual outcomes in patients with neovascular age‐related macular degeneration (nAMD).
Petri Purola, Pekko Hujanen, Hannu Uusitalo, Hannele Uusitalo‐Järvinen   +3 more
wiley   +1 more source

Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines

Indian Journal of Ophthalmology, 2016
The purpose of the study was to review the current evidence and design a diabetic macular edema (DME) management guideline specific for India. The published DME guidelines from different organizations and publications were weighed against the practice ...
Taraprasad Das, Ajay Aurora, Jay Chhablani, Anantharaman Giridhar, Atul Kumar, Rajiv Raman, Manish Nagpal, Raja Narayanan, Sundaram Natarajan, Kim Ramasamay, Mudit Tyagi, Lalit Verma   +11 more
doaj   +1 more source

Comparison of Efficacy of Suprachoroidal Triamcinolone Acetonide Alone or in Combination With Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema: A Prospective Comparative Study. [PDF]

Health Sci Rep
ABSTRACT Background and Aims This study was designed to evaluate the safety, efficacy, and durability of suprachoroidal triamcinolone acetonide, administered either alone or in combination with intravitreal bevacizumab (IVB), in the treatment of diabetic macular edema (DME). Methods This prospective comparative interventional study was conducted in the
Ghaffar MT, Khan AA, Bokhari MH, Majhu TM, Anwar F, Ahmed CN, Saleh A.   +6 more
europepmc   +2 more sources

Diabetic macular edema: Evidence-based management

Indian Journal of Ophthalmology, 2018
Diabetic macular edema (DME) is the most common cause of vision loss in patients with diabetic retinopathy with an increasing prevalence tied to the global epidemic in type 2 diabetes mellitus.
D. Browning, M. W. Stewart, Cho-Ping Lee
semanticscholar   +1 more source